Global Famciclovir API Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Famciclovir API market size is predicted to grow from US$ 13.3 million in 2025 to US$ 15.3 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Famciclovir API Industry Forecast” looks at past sales and reviews total world Famciclovir API sales in 2024, providing a comprehensive analysis by region and market sector of projected Famciclovir API sales for 2025 through 2031. With Famciclovir API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Famciclovir API industry.
This Insight Report provides a comprehensive analysis of the global Famciclovir API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Famciclovir API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Famciclovir API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Famciclovir API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Famciclovir API.
This report presents a comprehensive overview, market shares, and growth opportunities of Famciclovir API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Famciclovir API market?
What factors are driving Famciclovir API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Famciclovir API market opportunities vary by end market size?
How does Famciclovir API break out by Type, by Application?
The global Famciclovir API market size is predicted to grow from US$ 13.3 million in 2025 to US$ 15.3 million in 2031; it is expected to grow at a CAGR of 2.4% from 2025 to 2031.
Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.
Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.
Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.
Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Famciclovir API Industry Forecast” looks at past sales and reviews total world Famciclovir API sales in 2024, providing a comprehensive analysis by region and market sector of projected Famciclovir API sales for 2025 through 2031. With Famciclovir API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Famciclovir API industry.
This Insight Report provides a comprehensive analysis of the global Famciclovir API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Famciclovir API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Famciclovir API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Famciclovir API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Famciclovir API.
This report presents a comprehensive overview, market shares, and growth opportunities of Famciclovir API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Insourced
- Outsourced
- Others
- Tablet Product
- Capsule Product
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chongqing Shenghuaxi Pharma
- Aurobindo Pharma Limited
- Apotex Pharmachem
- Changzhou Kony Pharma Co
- Teva Pharmaceutical Industries
- Olon
- Fuan Pharmaceutical
- Zhejiang Charioteer Pharmaceutical
- Jialin Pharmaceutical
- Zhejiang Hisun
- Hetero
What is the 10-year outlook for the global Famciclovir API market?
What factors are driving Famciclovir API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Famciclovir API market opportunities vary by end market size?
How does Famciclovir API break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Famciclovir API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Famciclovir API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Famciclovir API by Country/Region, 2020, 2024 & 2031
2.2 Famciclovir API Segment by Type
2.2.1 Insourced
2.2.2 Outsourced
2.2.3 Others
2.3 Famciclovir API Sales by Type
2.3.1 Global Famciclovir API Sales Market Share by Type (2020-2025)
2.3.2 Global Famciclovir API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Famciclovir API Sale Price by Type (2020-2025)
2.4 Famciclovir API Segment by Application
2.4.1 Tablet Product
2.4.2 Capsule Product
2.4.3 Others
2.5 Famciclovir API Sales by Application
2.5.1 Global Famciclovir API Sale Market Share by Application (2020-2025)
2.5.2 Global Famciclovir API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Famciclovir API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Famciclovir API Breakdown Data by Company
3.1.1 Global Famciclovir API Annual Sales by Company (2020-2025)
3.1.2 Global Famciclovir API Sales Market Share by Company (2020-2025)
3.2 Global Famciclovir API Annual Revenue by Company (2020-2025)
3.2.1 Global Famciclovir API Revenue by Company (2020-2025)
3.2.2 Global Famciclovir API Revenue Market Share by Company (2020-2025)
3.3 Global Famciclovir API Sale Price by Company
3.4 Key Manufacturers Famciclovir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Famciclovir API Product Location Distribution
3.4.2 Players Famciclovir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAMCICLOVIR API BY GEOGRAPHIC REGION
4.1 World Historic Famciclovir API Market Size by Geographic Region (2020-2025)
4.1.1 Global Famciclovir API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Famciclovir API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Famciclovir API Market Size by Country/Region (2020-2025)
4.2.1 Global Famciclovir API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Famciclovir API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Famciclovir API Sales Growth
4.4 APAC Famciclovir API Sales Growth
4.5 Europe Famciclovir API Sales Growth
4.6 Middle East & Africa Famciclovir API Sales Growth
5 AMERICAS
5.1 Americas Famciclovir API Sales by Country
5.1.1 Americas Famciclovir API Sales by Country (2020-2025)
5.1.2 Americas Famciclovir API Revenue by Country (2020-2025)
5.2 Americas Famciclovir API Sales by Type (2020-2025)
5.3 Americas Famciclovir API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Famciclovir API Sales by Region
6.1.1 APAC Famciclovir API Sales by Region (2020-2025)
6.1.2 APAC Famciclovir API Revenue by Region (2020-2025)
6.2 APAC Famciclovir API Sales by Type (2020-2025)
6.3 APAC Famciclovir API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Famciclovir API by Country
7.1.1 Europe Famciclovir API Sales by Country (2020-2025)
7.1.2 Europe Famciclovir API Revenue by Country (2020-2025)
7.2 Europe Famciclovir API Sales by Type (2020-2025)
7.3 Europe Famciclovir API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Famciclovir API by Country
8.1.1 Middle East & Africa Famciclovir API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Famciclovir API Revenue by Country (2020-2025)
8.2 Middle East & Africa Famciclovir API Sales by Type (2020-2025)
8.3 Middle East & Africa Famciclovir API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Famciclovir API
10.3 Manufacturing Process Analysis of Famciclovir API
10.4 Industry Chain Structure of Famciclovir API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Famciclovir API Distributors
11.3 Famciclovir API Customer
12 WORLD FORECAST REVIEW FOR FAMCICLOVIR API BY GEOGRAPHIC REGION
12.1 Global Famciclovir API Market Size Forecast by Region
12.1.1 Global Famciclovir API Forecast by Region (2026-2031)
12.1.2 Global Famciclovir API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Famciclovir API Forecast by Type (2026-2031)
12.7 Global Famciclovir API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Shenghuaxi Pharma
13.1.1 Chongqing Shenghuaxi Pharma Company Information
13.1.2 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolios and Specifications
13.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Chongqing Shenghuaxi Pharma Main Business Overview
13.1.5 Chongqing Shenghuaxi Pharma Latest Developments
13.2 Aurobindo Pharma Limited
13.2.1 Aurobindo Pharma Limited Company Information
13.2.2 Aurobindo Pharma Limited Famciclovir API Product Portfolios and Specifications
13.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Aurobindo Pharma Limited Main Business Overview
13.2.5 Aurobindo Pharma Limited Latest Developments
13.3 Apotex Pharmachem
13.3.1 Apotex Pharmachem Company Information
13.3.2 Apotex Pharmachem Famciclovir API Product Portfolios and Specifications
13.3.3 Apotex Pharmachem Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Apotex Pharmachem Main Business Overview
13.3.5 Apotex Pharmachem Latest Developments
13.4 Changzhou Kony Pharma Co
13.4.1 Changzhou Kony Pharma Co Company Information
13.4.2 Changzhou Kony Pharma Co Famciclovir API Product Portfolios and Specifications
13.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Changzhou Kony Pharma Co Main Business Overview
13.4.5 Changzhou Kony Pharma Co Latest Developments
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Information
13.5.2 Teva Pharmaceutical Industries Famciclovir API Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Teva Pharmaceutical Industries Main Business Overview
13.5.5 Teva Pharmaceutical Industries Latest Developments
13.6 Olon
13.6.1 Olon Company Information
13.6.2 Olon Famciclovir API Product Portfolios and Specifications
13.6.3 Olon Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Olon Main Business Overview
13.6.5 Olon Latest Developments
13.7 Fuan Pharmaceutical
13.7.1 Fuan Pharmaceutical Company Information
13.7.2 Fuan Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.7.3 Fuan Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fuan Pharmaceutical Main Business Overview
13.7.5 Fuan Pharmaceutical Latest Developments
13.8 Zhejiang Charioteer Pharmaceutical
13.8.1 Zhejiang Charioteer Pharmaceutical Company Information
13.8.2 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Zhejiang Charioteer Pharmaceutical Main Business Overview
13.8.5 Zhejiang Charioteer Pharmaceutical Latest Developments
13.9 Jialin Pharmaceutical
13.9.1 Jialin Pharmaceutical Company Information
13.9.2 Jialin Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.9.3 Jialin Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Jialin Pharmaceutical Main Business Overview
13.9.5 Jialin Pharmaceutical Latest Developments
13.10 Zhejiang Hisun
13.10.1 Zhejiang Hisun Company Information
13.10.2 Zhejiang Hisun Famciclovir API Product Portfolios and Specifications
13.10.3 Zhejiang Hisun Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Zhejiang Hisun Main Business Overview
13.10.5 Zhejiang Hisun Latest Developments
13.11 Hetero
13.11.1 Hetero Company Information
13.11.2 Hetero Famciclovir API Product Portfolios and Specifications
13.11.3 Hetero Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hetero Main Business Overview
13.11.5 Hetero Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Famciclovir API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Famciclovir API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Insourced
Table 4. Major Players of Outsourced
Table 5. Major Players of Others
Table 6. GlobalFamciclovir API Sales byType (2020-2025) & (KG)
Table 7. GlobalFamciclovir API Sales Market Share byType (2020-2025)
Table 8. GlobalFamciclovir API Revenue byType (2020-2025) & ($ million)
Table 9. GlobalFamciclovir API Revenue Market Share byType (2020-2025)
Table 10. GlobalFamciclovir API Sale Price byType (2020-2025) & (US$/KG)
Table 11. GlobalFamciclovir API Sale by Application (2020-2025) & (KG)
Table 12. GlobalFamciclovir API Sale Market Share by Application (2020-2025)
Table 13. GlobalFamciclovir API Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalFamciclovir API Revenue Market Share by Application (2020-2025)
Table 15. GlobalFamciclovir API Sale Price by Application (2020-2025) & (US$/KG)
Table 16. GlobalFamciclovir API Sales by Company (2020-2025) & (KG)
Table 17. GlobalFamciclovir API Sales Market Share by Company (2020-2025)
Table 18. GlobalFamciclovir API Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalFamciclovir API Revenue Market Share by Company (2020-2025)
Table 20. GlobalFamciclovir API Sale Price by Company (2020-2025) & (US$/KG)
Table 21. Key ManufacturersFamciclovir API Producing Area Distribution and Sales Area
Table 22. PlayersFamciclovir API Products Offered
Table 23.Famciclovir API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalFamciclovir API Sales by Geographic Region (2020-2025) & (KG)
Table 27. GlobalFamciclovir API Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalFamciclovir API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalFamciclovir API Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalFamciclovir API Sales by Country/Region (2020-2025) & (KG)
Table 31. GlobalFamciclovir API Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalFamciclovir API Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalFamciclovir API Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasFamciclovir API Sales by Country (2020-2025) & (KG)
Table 35. AmericasFamciclovir API Sales Market Share by Country (2020-2025)
Table 36. AmericasFamciclovir API Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasFamciclovir API Sales byType (2020-2025) & (KG)
Table 38. AmericasFamciclovir API Sales by Application (2020-2025) & (KG)
Table 39. APACFamciclovir API Sales by Region (2020-2025) & (KG)
Table 40. APACFamciclovir API Sales Market Share by Region (2020-2025)
Table 41. APACFamciclovir API Revenue by Region (2020-2025) & ($ millions)
Table 42. APACFamciclovir API Sales byType (2020-2025) & (KG)
Table 43. APACFamciclovir API Sales by Application (2020-2025) & (KG)
Table 44. EuropeFamciclovir API Sales by Country (2020-2025) & (KG)
Table 45. EuropeFamciclovir API Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeFamciclovir API Sales byType (2020-2025) & (KG)
Table 47. EuropeFamciclovir API Sales by Application (2020-2025) & (KG)
Table 48. Middle East & AfricaFamciclovir API Sales by Country (2020-2025) & (KG)
Table 49. Middle East & AfricaFamciclovir API Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaFamciclovir API Sales byType (2020-2025) & (KG)
Table 51. Middle East & AfricaFamciclovir API Sales by Application (2020-2025) & (KG)
Table 52. Key Market Drivers & Growth Opportunities ofFamciclovir API
Table 53. Key Market Challenges & Risks ofFamciclovir API
Table 54. Key IndustryTrends ofFamciclovir API
Table 55.Famciclovir API Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Famciclovir API Distributors List
Table 58.Famciclovir API Customer List
Table 59. GlobalFamciclovir API SalesForecast by Region (2026-2031) & (KG)
Table 60. GlobalFamciclovir API RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasFamciclovir API SalesForecast by Country (2026-2031) & (KG)
Table 62. AmericasFamciclovir API Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACFamciclovir API SalesForecast by Region (2026-2031) & (KG)
Table 64. APACFamciclovir API Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeFamciclovir API SalesForecast by Country (2026-2031) & (KG)
Table 66. EuropeFamciclovir API RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaFamciclovir API SalesForecast by Country (2026-2031) & (KG)
Table 68. Middle East & AfricaFamciclovir API RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalFamciclovir API SalesForecast byType (2026-2031) & (KG)
Table 70. GlobalFamciclovir API RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalFamciclovir API SalesForecast by Application (2026-2031) & (KG)
Table 72. GlobalFamciclovir API RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Chongqing Shenghuaxi Pharma Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 74. Chongqing Shenghuaxi PharmaFamciclovir API Product Portfolios and Specifications
Table 75. Chongqing Shenghuaxi PharmaFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 76. Chongqing Shenghuaxi Pharma Main Business
Table 77. Chongqing Shenghuaxi Pharma Latest Developments
Table 78. Aurobindo Pharma Limited Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 79. Aurobindo Pharma LimitedFamciclovir API Product Portfolios and Specifications
Table 80. Aurobindo Pharma LimitedFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 81. Aurobindo Pharma Limited Main Business
Table 82. Aurobindo Pharma Limited Latest Developments
Table 83. Apotex Pharmachem Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 84. Apotex PharmachemFamciclovir API Product Portfolios and Specifications
Table 85. Apotex PharmachemFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 86. Apotex Pharmachem Main Business
Table 87. Apotex Pharmachem Latest Developments
Table 88. Changzhou Kony Pharma Co Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 89. Changzhou Kony Pharma CoFamciclovir API Product Portfolios and Specifications
Table 90. Changzhou Kony Pharma CoFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 91. Changzhou Kony Pharma Co Main Business
Table 92. Changzhou Kony Pharma Co Latest Developments
Table 93.Teva Pharmaceutical Industries Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 94.Teva Pharmaceutical IndustriesFamciclovir API Product Portfolios and Specifications
Table 95.Teva Pharmaceutical IndustriesFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 96.Teva Pharmaceutical Industries Main Business
Table 97.Teva Pharmaceutical Industries Latest Developments
Table 98. Olon Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 99. OlonFamciclovir API Product Portfolios and Specifications
Table 100. OlonFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 101. Olon Main Business
Table 102. Olon Latest Developments
Table 103.Fuan Pharmaceutical Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 104.Fuan PharmaceuticalFamciclovir API Product Portfolios and Specifications
Table 105.Fuan PharmaceuticalFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 106.Fuan Pharmaceutical Main Business
Table 107.Fuan Pharmaceutical Latest Developments
Table 108. Zhejiang Charioteer Pharmaceutical Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhejiang Charioteer PharmaceuticalFamciclovir API Product Portfolios and Specifications
Table 110. Zhejiang Charioteer PharmaceuticalFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 111. Zhejiang Charioteer Pharmaceutical Main Business
Table 112. Zhejiang Charioteer Pharmaceutical Latest Developments
Table 113. Jialin Pharmaceutical Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 114. Jialin PharmaceuticalFamciclovir API Product Portfolios and Specifications
Table 115. Jialin PharmaceuticalFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 116. Jialin Pharmaceutical Main Business
Table 117. Jialin Pharmaceutical Latest Developments
Table 118. Zhejiang Hisun Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhejiang HisunFamciclovir API Product Portfolios and Specifications
Table 120. Zhejiang HisunFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 121. Zhejiang Hisun Main Business
Table 122. Zhejiang Hisun Latest Developments
Table 123. Hetero Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 124. HeteroFamciclovir API Product Portfolios and Specifications
Table 125. HeteroFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 126. Hetero Main Business
Table 127. Hetero Latest Developments
LIST OFFIGURES
Figure 1. Picture ofFamciclovir API
Figure 2.Famciclovir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFamciclovir API Sales Growth Rate 2020-2031 (KG)
Figure 7. GlobalFamciclovir API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Famciclovir API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Famciclovir API Sales Market Share by Country/Region (2024)
Figure 10.Famciclovir API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Insourced
Figure 12. Product Picture of Outsourced
Figure 13. Product Picture of Others
Figure 14. GlobalFamciclovir API Sales Market Share byType in 2025
Figure 15. GlobalFamciclovir API Revenue Market Share byType (2020-2025)
Figure 16.Famciclovir API Consumed inTablet Product
Figure 17. GlobalFamciclovir API Market:Tablet Product (2020-2025) & (KG)
Figure 18.Famciclovir API Consumed in Capsule Product
Figure 19. GlobalFamciclovir API Market: Capsule Product (2020-2025) & (KG)
Figure 20.Famciclovir API Consumed in Others
Figure 21. GlobalFamciclovir API Market: Others (2020-2025) & (KG)
Figure 22. GlobalFamciclovir API Sale Market Share by Application (2024)
Figure 23. GlobalFamciclovir API Revenue Market Share by Application in 2025
Figure 24.Famciclovir API Sales by Company in 2025 (KG)
Figure 25. GlobalFamciclovir API Sales Market Share by Company in 2025
Figure 26.Famciclovir API Revenue by Company in 2025 ($ millions)
Figure 27. GlobalFamciclovir API Revenue Market Share by Company in 2025
Figure 28. GlobalFamciclovir API Sales Market Share by Geographic Region (2020-2025)
Figure 29. GlobalFamciclovir API Revenue Market Share by Geographic Region in 2025
Figure 30. AmericasFamciclovir API Sales 2020-2025 (KG)
Figure 31. AmericasFamciclovir API Revenue 2020-2025 ($ millions)
Figure 32. APACFamciclovir API Sales 2020-2025 (KG)
Figure 33. APACFamciclovir API Revenue 2020-2025 ($ millions)
Figure 34. EuropeFamciclovir API Sales 2020-2025 (KG)
Figure 35. EuropeFamciclovir API Revenue 2020-2025 ($ millions)
Figure 36. Middle East & AfricaFamciclovir API Sales 2020-2025 (KG)
Figure 37. Middle East & AfricaFamciclovir API Revenue 2020-2025 ($ millions)
Figure 38. AmericasFamciclovir API Sales Market Share by Country in 2025
Figure 39. AmericasFamciclovir API Revenue Market Share by Country (2020-2025)
Figure 40. AmericasFamciclovir API Sales Market Share byType (2020-2025)
Figure 41. AmericasFamciclovir API Sales Market Share by Application (2020-2025)
Figure 42. United StatesFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 43. CanadaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 44. MexicoFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 45. BrazilFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 46. APACFamciclovir API Sales Market Share by Region in 2025
Figure 47. APACFamciclovir API Revenue Market Share by Region (2020-2025)
Figure 48. APACFamciclovir API Sales Market Share byType (2020-2025)
Figure 49. APACFamciclovir API Sales Market Share by Application (2020-2025)
Figure 50. ChinaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 51. JapanFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 52. South KoreaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast AsiaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 54. IndiaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 55. AustraliaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwanFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 57. EuropeFamciclovir API Sales Market Share by Country in 2025
Figure 58. EuropeFamciclovir API Revenue Market Share by Country (2020-2025)
Figure 59. EuropeFamciclovir API Sales Market Share byType (2020-2025)
Figure 60. EuropeFamciclovir API Sales Market Share by Application (2020-2025)
Figure 61. GermanyFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 62.FranceFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 63. UKFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 64. ItalyFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 65. RussiaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & AfricaFamciclovir API Sales Market Share by Country (2020-2025)
Figure 67. Middle East & AfricaFamciclovir API Sales Market Share byType (2020-2025)
Figure 68. Middle East & AfricaFamciclovir API Sales Market Share by Application (2020-2025)
Figure 69. EgyptFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 70. South AfricaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 71. IsraelFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 72.TurkeyFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC CountriesFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis ofFamciclovir API in 2025
Figure 75. Manufacturing Process Analysis ofFamciclovir API
Figure 76. Industry Chain Structure ofFamciclovir API
Figure 77. Channels of Distribution
Figure 78. GlobalFamciclovir API Sales MarketForecast by Region (2026-2031)
Figure 79. GlobalFamciclovir API Revenue Market ShareForecast by Region (2026-2031)
Figure 80. GlobalFamciclovir API Sales Market ShareForecast byType (2026-2031)
Figure 81. GlobalFamciclovir API Revenue Market ShareForecast byType (2026-2031)
Figure 82. GlobalFamciclovir API Sales Market ShareForecast by Application (2026-2031)
Figure 83. GlobalFamciclovir API Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Famciclovir API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Famciclovir API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Famciclovir API by Country/Region, 2020, 2024 & 2031
2.2 Famciclovir API Segment by Type
2.2.1 Insourced
2.2.2 Outsourced
2.2.3 Others
2.3 Famciclovir API Sales by Type
2.3.1 Global Famciclovir API Sales Market Share by Type (2020-2025)
2.3.2 Global Famciclovir API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Famciclovir API Sale Price by Type (2020-2025)
2.4 Famciclovir API Segment by Application
2.4.1 Tablet Product
2.4.2 Capsule Product
2.4.3 Others
2.5 Famciclovir API Sales by Application
2.5.1 Global Famciclovir API Sale Market Share by Application (2020-2025)
2.5.2 Global Famciclovir API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Famciclovir API Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Famciclovir API Breakdown Data by Company
3.1.1 Global Famciclovir API Annual Sales by Company (2020-2025)
3.1.2 Global Famciclovir API Sales Market Share by Company (2020-2025)
3.2 Global Famciclovir API Annual Revenue by Company (2020-2025)
3.2.1 Global Famciclovir API Revenue by Company (2020-2025)
3.2.2 Global Famciclovir API Revenue Market Share by Company (2020-2025)
3.3 Global Famciclovir API Sale Price by Company
3.4 Key Manufacturers Famciclovir API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Famciclovir API Product Location Distribution
3.4.2 Players Famciclovir API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FAMCICLOVIR API BY GEOGRAPHIC REGION
4.1 World Historic Famciclovir API Market Size by Geographic Region (2020-2025)
4.1.1 Global Famciclovir API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Famciclovir API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Famciclovir API Market Size by Country/Region (2020-2025)
4.2.1 Global Famciclovir API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Famciclovir API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Famciclovir API Sales Growth
4.4 APAC Famciclovir API Sales Growth
4.5 Europe Famciclovir API Sales Growth
4.6 Middle East & Africa Famciclovir API Sales Growth
5 AMERICAS
5.1 Americas Famciclovir API Sales by Country
5.1.1 Americas Famciclovir API Sales by Country (2020-2025)
5.1.2 Americas Famciclovir API Revenue by Country (2020-2025)
5.2 Americas Famciclovir API Sales by Type (2020-2025)
5.3 Americas Famciclovir API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Famciclovir API Sales by Region
6.1.1 APAC Famciclovir API Sales by Region (2020-2025)
6.1.2 APAC Famciclovir API Revenue by Region (2020-2025)
6.2 APAC Famciclovir API Sales by Type (2020-2025)
6.3 APAC Famciclovir API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Famciclovir API by Country
7.1.1 Europe Famciclovir API Sales by Country (2020-2025)
7.1.2 Europe Famciclovir API Revenue by Country (2020-2025)
7.2 Europe Famciclovir API Sales by Type (2020-2025)
7.3 Europe Famciclovir API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Famciclovir API by Country
8.1.1 Middle East & Africa Famciclovir API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Famciclovir API Revenue by Country (2020-2025)
8.2 Middle East & Africa Famciclovir API Sales by Type (2020-2025)
8.3 Middle East & Africa Famciclovir API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Famciclovir API
10.3 Manufacturing Process Analysis of Famciclovir API
10.4 Industry Chain Structure of Famciclovir API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Famciclovir API Distributors
11.3 Famciclovir API Customer
12 WORLD FORECAST REVIEW FOR FAMCICLOVIR API BY GEOGRAPHIC REGION
12.1 Global Famciclovir API Market Size Forecast by Region
12.1.1 Global Famciclovir API Forecast by Region (2026-2031)
12.1.2 Global Famciclovir API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Famciclovir API Forecast by Type (2026-2031)
12.7 Global Famciclovir API Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Shenghuaxi Pharma
13.1.1 Chongqing Shenghuaxi Pharma Company Information
13.1.2 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolios and Specifications
13.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Chongqing Shenghuaxi Pharma Main Business Overview
13.1.5 Chongqing Shenghuaxi Pharma Latest Developments
13.2 Aurobindo Pharma Limited
13.2.1 Aurobindo Pharma Limited Company Information
13.2.2 Aurobindo Pharma Limited Famciclovir API Product Portfolios and Specifications
13.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Aurobindo Pharma Limited Main Business Overview
13.2.5 Aurobindo Pharma Limited Latest Developments
13.3 Apotex Pharmachem
13.3.1 Apotex Pharmachem Company Information
13.3.2 Apotex Pharmachem Famciclovir API Product Portfolios and Specifications
13.3.3 Apotex Pharmachem Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Apotex Pharmachem Main Business Overview
13.3.5 Apotex Pharmachem Latest Developments
13.4 Changzhou Kony Pharma Co
13.4.1 Changzhou Kony Pharma Co Company Information
13.4.2 Changzhou Kony Pharma Co Famciclovir API Product Portfolios and Specifications
13.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Changzhou Kony Pharma Co Main Business Overview
13.4.5 Changzhou Kony Pharma Co Latest Developments
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Information
13.5.2 Teva Pharmaceutical Industries Famciclovir API Product Portfolios and Specifications
13.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Teva Pharmaceutical Industries Main Business Overview
13.5.5 Teva Pharmaceutical Industries Latest Developments
13.6 Olon
13.6.1 Olon Company Information
13.6.2 Olon Famciclovir API Product Portfolios and Specifications
13.6.3 Olon Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Olon Main Business Overview
13.6.5 Olon Latest Developments
13.7 Fuan Pharmaceutical
13.7.1 Fuan Pharmaceutical Company Information
13.7.2 Fuan Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.7.3 Fuan Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fuan Pharmaceutical Main Business Overview
13.7.5 Fuan Pharmaceutical Latest Developments
13.8 Zhejiang Charioteer Pharmaceutical
13.8.1 Zhejiang Charioteer Pharmaceutical Company Information
13.8.2 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Zhejiang Charioteer Pharmaceutical Main Business Overview
13.8.5 Zhejiang Charioteer Pharmaceutical Latest Developments
13.9 Jialin Pharmaceutical
13.9.1 Jialin Pharmaceutical Company Information
13.9.2 Jialin Pharmaceutical Famciclovir API Product Portfolios and Specifications
13.9.3 Jialin Pharmaceutical Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Jialin Pharmaceutical Main Business Overview
13.9.5 Jialin Pharmaceutical Latest Developments
13.10 Zhejiang Hisun
13.10.1 Zhejiang Hisun Company Information
13.10.2 Zhejiang Hisun Famciclovir API Product Portfolios and Specifications
13.10.3 Zhejiang Hisun Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Zhejiang Hisun Main Business Overview
13.10.5 Zhejiang Hisun Latest Developments
13.11 Hetero
13.11.1 Hetero Company Information
13.11.2 Hetero Famciclovir API Product Portfolios and Specifications
13.11.3 Hetero Famciclovir API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hetero Main Business Overview
13.11.5 Hetero Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Famciclovir API Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Famciclovir API Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Insourced
Table 4. Major Players of Outsourced
Table 5. Major Players of Others
Table 6. GlobalFamciclovir API Sales byType (2020-2025) & (KG)
Table 7. GlobalFamciclovir API Sales Market Share byType (2020-2025)
Table 8. GlobalFamciclovir API Revenue byType (2020-2025) & ($ million)
Table 9. GlobalFamciclovir API Revenue Market Share byType (2020-2025)
Table 10. GlobalFamciclovir API Sale Price byType (2020-2025) & (US$/KG)
Table 11. GlobalFamciclovir API Sale by Application (2020-2025) & (KG)
Table 12. GlobalFamciclovir API Sale Market Share by Application (2020-2025)
Table 13. GlobalFamciclovir API Revenue by Application (2020-2025) & ($ million)
Table 14. GlobalFamciclovir API Revenue Market Share by Application (2020-2025)
Table 15. GlobalFamciclovir API Sale Price by Application (2020-2025) & (US$/KG)
Table 16. GlobalFamciclovir API Sales by Company (2020-2025) & (KG)
Table 17. GlobalFamciclovir API Sales Market Share by Company (2020-2025)
Table 18. GlobalFamciclovir API Revenue by Company (2020-2025) & ($ millions)
Table 19. GlobalFamciclovir API Revenue Market Share by Company (2020-2025)
Table 20. GlobalFamciclovir API Sale Price by Company (2020-2025) & (US$/KG)
Table 21. Key ManufacturersFamciclovir API Producing Area Distribution and Sales Area
Table 22. PlayersFamciclovir API Products Offered
Table 23.Famciclovir API Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. GlobalFamciclovir API Sales by Geographic Region (2020-2025) & (KG)
Table 27. GlobalFamciclovir API Sales Market Share Geographic Region (2020-2025)
Table 28. GlobalFamciclovir API Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. GlobalFamciclovir API Revenue Market Share by Geographic Region (2020-2025)
Table 30. GlobalFamciclovir API Sales by Country/Region (2020-2025) & (KG)
Table 31. GlobalFamciclovir API Sales Market Share by Country/Region (2020-2025)
Table 32. GlobalFamciclovir API Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. GlobalFamciclovir API Revenue Market Share by Country/Region (2020-2025)
Table 34. AmericasFamciclovir API Sales by Country (2020-2025) & (KG)
Table 35. AmericasFamciclovir API Sales Market Share by Country (2020-2025)
Table 36. AmericasFamciclovir API Revenue by Country (2020-2025) & ($ millions)
Table 37. AmericasFamciclovir API Sales byType (2020-2025) & (KG)
Table 38. AmericasFamciclovir API Sales by Application (2020-2025) & (KG)
Table 39. APACFamciclovir API Sales by Region (2020-2025) & (KG)
Table 40. APACFamciclovir API Sales Market Share by Region (2020-2025)
Table 41. APACFamciclovir API Revenue by Region (2020-2025) & ($ millions)
Table 42. APACFamciclovir API Sales byType (2020-2025) & (KG)
Table 43. APACFamciclovir API Sales by Application (2020-2025) & (KG)
Table 44. EuropeFamciclovir API Sales by Country (2020-2025) & (KG)
Table 45. EuropeFamciclovir API Revenue by Country (2020-2025) & ($ millions)
Table 46. EuropeFamciclovir API Sales byType (2020-2025) & (KG)
Table 47. EuropeFamciclovir API Sales by Application (2020-2025) & (KG)
Table 48. Middle East & AfricaFamciclovir API Sales by Country (2020-2025) & (KG)
Table 49. Middle East & AfricaFamciclovir API Revenue Market Share by Country (2020-2025)
Table 50. Middle East & AfricaFamciclovir API Sales byType (2020-2025) & (KG)
Table 51. Middle East & AfricaFamciclovir API Sales by Application (2020-2025) & (KG)
Table 52. Key Market Drivers & Growth Opportunities ofFamciclovir API
Table 53. Key Market Challenges & Risks ofFamciclovir API
Table 54. Key IndustryTrends ofFamciclovir API
Table 55.Famciclovir API Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57.Famciclovir API Distributors List
Table 58.Famciclovir API Customer List
Table 59. GlobalFamciclovir API SalesForecast by Region (2026-2031) & (KG)
Table 60. GlobalFamciclovir API RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. AmericasFamciclovir API SalesForecast by Country (2026-2031) & (KG)
Table 62. AmericasFamciclovir API Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APACFamciclovir API SalesForecast by Region (2026-2031) & (KG)
Table 64. APACFamciclovir API Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. EuropeFamciclovir API SalesForecast by Country (2026-2031) & (KG)
Table 66. EuropeFamciclovir API RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & AfricaFamciclovir API SalesForecast by Country (2026-2031) & (KG)
Table 68. Middle East & AfricaFamciclovir API RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. GlobalFamciclovir API SalesForecast byType (2026-2031) & (KG)
Table 70. GlobalFamciclovir API RevenueForecast byType (2026-2031) & ($ millions)
Table 71. GlobalFamciclovir API SalesForecast by Application (2026-2031) & (KG)
Table 72. GlobalFamciclovir API RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Chongqing Shenghuaxi Pharma Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 74. Chongqing Shenghuaxi PharmaFamciclovir API Product Portfolios and Specifications
Table 75. Chongqing Shenghuaxi PharmaFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 76. Chongqing Shenghuaxi Pharma Main Business
Table 77. Chongqing Shenghuaxi Pharma Latest Developments
Table 78. Aurobindo Pharma Limited Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 79. Aurobindo Pharma LimitedFamciclovir API Product Portfolios and Specifications
Table 80. Aurobindo Pharma LimitedFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 81. Aurobindo Pharma Limited Main Business
Table 82. Aurobindo Pharma Limited Latest Developments
Table 83. Apotex Pharmachem Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 84. Apotex PharmachemFamciclovir API Product Portfolios and Specifications
Table 85. Apotex PharmachemFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 86. Apotex Pharmachem Main Business
Table 87. Apotex Pharmachem Latest Developments
Table 88. Changzhou Kony Pharma Co Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 89. Changzhou Kony Pharma CoFamciclovir API Product Portfolios and Specifications
Table 90. Changzhou Kony Pharma CoFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 91. Changzhou Kony Pharma Co Main Business
Table 92. Changzhou Kony Pharma Co Latest Developments
Table 93.Teva Pharmaceutical Industries Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 94.Teva Pharmaceutical IndustriesFamciclovir API Product Portfolios and Specifications
Table 95.Teva Pharmaceutical IndustriesFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 96.Teva Pharmaceutical Industries Main Business
Table 97.Teva Pharmaceutical Industries Latest Developments
Table 98. Olon Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 99. OlonFamciclovir API Product Portfolios and Specifications
Table 100. OlonFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 101. Olon Main Business
Table 102. Olon Latest Developments
Table 103.Fuan Pharmaceutical Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 104.Fuan PharmaceuticalFamciclovir API Product Portfolios and Specifications
Table 105.Fuan PharmaceuticalFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 106.Fuan Pharmaceutical Main Business
Table 107.Fuan Pharmaceutical Latest Developments
Table 108. Zhejiang Charioteer Pharmaceutical Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhejiang Charioteer PharmaceuticalFamciclovir API Product Portfolios and Specifications
Table 110. Zhejiang Charioteer PharmaceuticalFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 111. Zhejiang Charioteer Pharmaceutical Main Business
Table 112. Zhejiang Charioteer Pharmaceutical Latest Developments
Table 113. Jialin Pharmaceutical Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 114. Jialin PharmaceuticalFamciclovir API Product Portfolios and Specifications
Table 115. Jialin PharmaceuticalFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 116. Jialin Pharmaceutical Main Business
Table 117. Jialin Pharmaceutical Latest Developments
Table 118. Zhejiang Hisun Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 119. Zhejiang HisunFamciclovir API Product Portfolios and Specifications
Table 120. Zhejiang HisunFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 121. Zhejiang Hisun Main Business
Table 122. Zhejiang Hisun Latest Developments
Table 123. Hetero Basic Information,Famciclovir API Manufacturing Base, Sales Area and Its Competitors
Table 124. HeteroFamciclovir API Product Portfolios and Specifications
Table 125. HeteroFamciclovir API Sales (KG), Revenue ($ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 126. Hetero Main Business
Table 127. Hetero Latest Developments
LIST OFFIGURES
Figure 1. Picture ofFamciclovir API
Figure 2.Famciclovir API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalFamciclovir API Sales Growth Rate 2020-2031 (KG)
Figure 7. GlobalFamciclovir API Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Famciclovir API Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Famciclovir API Sales Market Share by Country/Region (2024)
Figure 10.Famciclovir API Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Insourced
Figure 12. Product Picture of Outsourced
Figure 13. Product Picture of Others
Figure 14. GlobalFamciclovir API Sales Market Share byType in 2025
Figure 15. GlobalFamciclovir API Revenue Market Share byType (2020-2025)
Figure 16.Famciclovir API Consumed inTablet Product
Figure 17. GlobalFamciclovir API Market:Tablet Product (2020-2025) & (KG)
Figure 18.Famciclovir API Consumed in Capsule Product
Figure 19. GlobalFamciclovir API Market: Capsule Product (2020-2025) & (KG)
Figure 20.Famciclovir API Consumed in Others
Figure 21. GlobalFamciclovir API Market: Others (2020-2025) & (KG)
Figure 22. GlobalFamciclovir API Sale Market Share by Application (2024)
Figure 23. GlobalFamciclovir API Revenue Market Share by Application in 2025
Figure 24.Famciclovir API Sales by Company in 2025 (KG)
Figure 25. GlobalFamciclovir API Sales Market Share by Company in 2025
Figure 26.Famciclovir API Revenue by Company in 2025 ($ millions)
Figure 27. GlobalFamciclovir API Revenue Market Share by Company in 2025
Figure 28. GlobalFamciclovir API Sales Market Share by Geographic Region (2020-2025)
Figure 29. GlobalFamciclovir API Revenue Market Share by Geographic Region in 2025
Figure 30. AmericasFamciclovir API Sales 2020-2025 (KG)
Figure 31. AmericasFamciclovir API Revenue 2020-2025 ($ millions)
Figure 32. APACFamciclovir API Sales 2020-2025 (KG)
Figure 33. APACFamciclovir API Revenue 2020-2025 ($ millions)
Figure 34. EuropeFamciclovir API Sales 2020-2025 (KG)
Figure 35. EuropeFamciclovir API Revenue 2020-2025 ($ millions)
Figure 36. Middle East & AfricaFamciclovir API Sales 2020-2025 (KG)
Figure 37. Middle East & AfricaFamciclovir API Revenue 2020-2025 ($ millions)
Figure 38. AmericasFamciclovir API Sales Market Share by Country in 2025
Figure 39. AmericasFamciclovir API Revenue Market Share by Country (2020-2025)
Figure 40. AmericasFamciclovir API Sales Market Share byType (2020-2025)
Figure 41. AmericasFamciclovir API Sales Market Share by Application (2020-2025)
Figure 42. United StatesFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 43. CanadaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 44. MexicoFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 45. BrazilFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 46. APACFamciclovir API Sales Market Share by Region in 2025
Figure 47. APACFamciclovir API Revenue Market Share by Region (2020-2025)
Figure 48. APACFamciclovir API Sales Market Share byType (2020-2025)
Figure 49. APACFamciclovir API Sales Market Share by Application (2020-2025)
Figure 50. ChinaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 51. JapanFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 52. South KoreaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast AsiaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 54. IndiaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 55. AustraliaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwanFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 57. EuropeFamciclovir API Sales Market Share by Country in 2025
Figure 58. EuropeFamciclovir API Revenue Market Share by Country (2020-2025)
Figure 59. EuropeFamciclovir API Sales Market Share byType (2020-2025)
Figure 60. EuropeFamciclovir API Sales Market Share by Application (2020-2025)
Figure 61. GermanyFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 62.FranceFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 63. UKFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 64. ItalyFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 65. RussiaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & AfricaFamciclovir API Sales Market Share by Country (2020-2025)
Figure 67. Middle East & AfricaFamciclovir API Sales Market Share byType (2020-2025)
Figure 68. Middle East & AfricaFamciclovir API Sales Market Share by Application (2020-2025)
Figure 69. EgyptFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 70. South AfricaFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 71. IsraelFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 72.TurkeyFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC CountriesFamciclovir API Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis ofFamciclovir API in 2025
Figure 75. Manufacturing Process Analysis ofFamciclovir API
Figure 76. Industry Chain Structure ofFamciclovir API
Figure 77. Channels of Distribution
Figure 78. GlobalFamciclovir API Sales MarketForecast by Region (2026-2031)
Figure 79. GlobalFamciclovir API Revenue Market ShareForecast by Region (2026-2031)
Figure 80. GlobalFamciclovir API Sales Market ShareForecast byType (2026-2031)
Figure 81. GlobalFamciclovir API Revenue Market ShareForecast byType (2026-2031)
Figure 82. GlobalFamciclovir API Sales Market ShareForecast by Application (2026-2031)
Figure 83. GlobalFamciclovir API Revenue Market ShareForecast by Application (2026-2031)
